Clinical Trial Update: CIML NK Cell in Head & Neck Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating CIML NK cells in head and neck squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CIML NK Cell

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Squamous Cell Carcinoma of the Head and Neck, Recurrent Head and Neck Squamous Cell Carcinoma | Phase 1 | Status: COMPLETED